Q2 2026 saw 31% revenue and 27% adjusted EBITDA growth, driven by new Performance Suite launches and strong client renewals. Full-year guidance was raised, with 2027 revenue growth expected above 25% despite Medicaid headwinds. AI initiatives and new contracts support long-term margin and growth ta…
Evolent Health, Inc. reported results for the quarter ended 2026 with revenue rising to $652.52M from $444.33M a year earlier while the company narrowed its loss; diluted loss per share improved to ($0.25) from ($0.44).Financial Highlights¹ Reported as “Revenue (1)”. ² Reported as “Net loss attribu…
Healthcare solutions company Evolent Health NYSE:EVHwill be reporting earnings this Thursday before market hours. Here’s what to look for.Evolent Health missed analysts’ revenue expectations last quarter, reporting revenues of $496.2 million, up 2.6% year on year. It was a mixed quarter for the com…
